Description of institution
Founded in 1989 by Philippe Zitoun (CEO), NOTOCORD® has become an internationally renowned software publisher specializing in acquisition and analysis of physiological signals for experimental drug research.
With more than 1500 licenses installed worldwide in the major pharmaceutical companies, CROs, hospitals, public and academic research centers, our software is used every day by top scientists for their research in pre-clinical phases of new drug development: discovery, safety pharmacology and toxicology studies.
NOTOCORD®'s expertise covers cardiovascular, respiratory, electrophysiology and nervous system research areas. Our versatile software platform, NOTOCORD-hem™ Evolution, is compatible with the major acquisition hardware for optimal use of the customer's resources. With over 160 modules and applications available in our catalog for online analysis, display and data review, NOTOCORD® provides trustworthy solutions for customized studies. Our software provides flexible data handling and fast data reporting in Microsoft Excel®. It is designed to meet GLP and 21 CFR Part 11 requirements.
NOTOCORD is certified ISO 9001 since 2001 and a member or the Microsoft Certified Partner program since 2005.